PYC Therapeutics Limited (ASX:PYC)

PYC Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 23, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	992	755	560	191	207	493
Market Cap Growth	40.26%	34.90%	192.66%	-7.47%	-58.06%	46.25%
Enterprise Value	840	708	536	175	165	438
Last Close Price	1.70	1.29	1.19	0.55	0.64	1.52
PS Ratio	42.20	32.15	25.38	12.10	12.89	160.37
PB Ratio	5.83	4.44	6.91	6.73	5.14	9.14
P/TBV Ratio	5.98	4.56	7.33	8.14	5.92	10.19
EV/Sales Ratio	35.75	30.12	24.29	11.10	10.26	142.63
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.02	0.01
Asset Turnover	0.17	0.17	0.34	0.38	0.31	0.07
Quick Ratio	14.38	14.38	9.32	3.79	8.93	15.68
Current Ratio	14.41	14.41	9.40	3.79	8.95	15.71
Return on Equity (ROE)	-40.64%	-40.64%	-69.61%	-68.05%	-30.37%	-44.29%
Return on Assets (ROA)	-24.42%	-24.42%	-37.83%	-35.49%	-17.29%	-26.20%
Return on Capital (ROIC)	-26.47%	-26.47%	-43.79%	-41.90%	-18.64%	-27.38%
Return on Capital Employed (ROCE)	-31.40%	-31.40%	-47.30%	-81.50%	-34.90%	-34.30%
Earnings Yield	-5.07%	-6.66%	-6.74%	-11.91%	-6.71%	-3.60%
FCF Yield	-5.30%	-6.96%	-6.95%	-13.02%	-10.72%	-2.51%
Buyback Yield / Dilution	-27.16%	-27.16%	-22.59%	-0.93%	-2.89%	-12.58%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.